¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ±è¼öÁöÀÔ´Ï´Ù.
Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2020 ³â Immunity ¿¡ ÃâÆǵÈ
"Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
" ÀÔ´Ï´Ù.
SARS-Cov-2 °¨¿°½Ã ¿Ö ¾î¶² ȯÀÚµéÀº ȸº¹µÇ°í ´Ù¸¥ ȯÀÚµéÀº Á×´Â Áö, ¾î¶² ¸é¿ªÇÐÀû ¸ÞÄ¿´ÏÁòÀÌ ´Þ¶ó¼ ÀÓ»óÀûÀ¸·Î ´Ù¸¥ Çö»óÀ» º¸ÀÌ´Â Áö ¾Ë·ÁÁø ¹Ù°¡ °ÅÀÇ ¾ø½À´Ï´Ù. ÀÌ ³í¹®¿¡¼´Â SARS-CoV-2 specific humoral responses ¸¦ 22¸íÀÇ È¯ÀÚ¸¦ ÅëÇØ profiling ÇÏ¿© ȸº¹µÈ ȯÀÚ¿Í Á×Àº ȯÀÚ °£ ±¸º°µÇ´Â antibody signatures ¸¦ ¹ß°ßÇß½À´Ï´Ù. IgG ÀÇ °æ¿ì ±×·ì °£ Â÷ÀÌ°¡ ¾ø¾úÁö¸¸ spike specific humoral responses ´Â ȸº¹µÈ ȯÀڵ鿡°Ô¼ ³ô°Ô ³ªÅ¸³µÀ¸¸ç nucleocapsid ¿¡ ´ëÇÑ functional antibody ÀÇ ¹ÝÀÀÀº Á×Àº ȯÀڵ鿡°Ô¼ ³ô°Ô ³ªÅ¸³µ½À´Ï´Ù. µû¶ó¼ Ãʱâ Ç×ü ƯÀÌÀû, ±â´ÉÀû Ư¼ºÀº ȯÀÚÀÇ ÀÓ»óÀû Ư¼ºÀ» ´Ù¸£°Ô Çϴµ¥ ÁÖ¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù´Â °ÍÀ» ¹àÈù ³í¹®ÀÔ´Ï´Ù.
³í¹®¿¡¼ ´Ù·ç°í ÀÖ´Â Systems serology ¿Í virus vaccine °ü·Ã assay °øºÎ¸¦ À§ÇØ ¼±Á¤ÇÏ¿´½À´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
³í¹®»çÀÌÆ®: https://www.sciencedirect.com/science/article/pii/S1074761320303277?via%3Dihub